Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (131-140 of 528) with videos related to

Pageof 53
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer|January 7, 2020
RLIP controls receptor-ligand signaling by regulating clathrin-dependent endocytosisSharad S Singhal, Ravi Salgia, Nisan Verma, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|July 23, 2025
Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeuticsPankaj Garg, Gargi Singhal, David Horne, et al.
Cancer Letters|June 2, 2026
Inflammation-Driven Transcriptional Reprogramming in Prostate Cancer: Convergence of NFκB, JAK/STAT3, and Epigenetic Remodeling in Castration-Resistant DiseaseMadhu Krishna, Pankaj Garg, David Horne, et al.
Journal of Oncology Practice|July 26, 2018
Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung CancerAddie Hill, Jun Gong, Sharon Wilczynski, et al.
Seminars in Oncology|October 6, 2018
Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderlyAshwin Shinde, Richard Li, Jae Kim, et al.
Cancer Treatment and Research|June 19, 2019
Targeted Therapies in Non-small-Cell Lung CancerAddie Hill, Rohan Gupta, Dan Zhao, et al.
Journal of Clinical Medicine|August 6, 2020
Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational ResearchShanmuga Subbiah, Arin Nam, Natasha Garg, et al.
Medicine|November 12, 2020
Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case reportJeremy Fricke, Isa Mambetsariev, Rebecca Pharaon, et al.
Cancer Treatment and Research|August 23, 2025
Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in CancerPrakash Kulkarni, Sravani Ramisetty, Debora Bruno, et al.
Oncotarget|October 21, 2017
State-of-the-art considerations in small cell lung cancer brain metastasesRimas V Lukas, Vinai Gondi, David O Kamson, et al.
Pageof 53

Showing results (131-140 of 528) with videos related to

Sort By:
Pageof 53
Biochimica Et Biophysica Acta. Reviews on Cancer|January 7, 2020
RLIP controls receptor-ligand signaling by regulating clathrin-dependent endocytosisSharad S Singhal, Ravi Salgia, Nisan Verma, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|July 23, 2025
Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeuticsPankaj Garg, Gargi Singhal, David Horne, et al.
Cancer Letters|June 2, 2026
Inflammation-Driven Transcriptional Reprogramming in Prostate Cancer: Convergence of NFκB, JAK/STAT3, and Epigenetic Remodeling in Castration-Resistant DiseaseMadhu Krishna, Pankaj Garg, David Horne, et al.
Journal of Oncology Practice|July 26, 2018
Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung CancerAddie Hill, Jun Gong, Sharon Wilczynski, et al.
Seminars in Oncology|October 6, 2018
Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderlyAshwin Shinde, Richard Li, Jae Kim, et al.
Cancer Treatment and Research|June 19, 2019
Targeted Therapies in Non-small-Cell Lung CancerAddie Hill, Rohan Gupta, Dan Zhao, et al.
Journal of Clinical Medicine|August 6, 2020
Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational ResearchShanmuga Subbiah, Arin Nam, Natasha Garg, et al.
Medicine|November 12, 2020
Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case reportJeremy Fricke, Isa Mambetsariev, Rebecca Pharaon, et al.
Cancer Treatment and Research|August 23, 2025
Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in CancerPrakash Kulkarni, Sravani Ramisetty, Debora Bruno, et al.
Oncotarget|October 21, 2017
State-of-the-art considerations in small cell lung cancer brain metastasesRimas V Lukas, Vinai Gondi, David O Kamson, et al.
Pageof 53